Malek TR - Search Results

1

Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2.

Dwyer CJ, Ward NC, Pugliese A, Malek TR. Dwyer CJ, et al. Among authors: malek tr. Curr Diab Rep. 2016 Jun;16(6):46. doi: 10.1007/s11892-016-0739-1. Curr Diab Rep. 2016. PMID: 27076179 Free PMC article. Review.

2

Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.

Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, Oliver R, Malek TR, Ricordi C, Inverardi L. Molano RD, et al. Among authors: malek tr. Transplantation. 2003 Jun 15;75(11):1812-9. doi: 10.1097/01.TP.0000064622.54799.0E. Transplantation. 2003. PMID: 12811239

3

Tolerance, not immunity, crucially depends on IL-2.

Malek TR, Bayer AL. Malek TR, et al. Nat Rev Immunol. 2004 Sep;4(9):665-74. doi: 10.1038/nri1435. Nat Rev Immunol. 2004. PMID: 15343366 Review.

4

Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells.

Yu A, Malek TR. Yu A, et al. Among authors: malek tr. J Immunol. 2006 Oct 15;177(8):5115-21. doi: 10.4049/jimmunol.177.8.5115. J Immunol. 2006. PMID: 17015695

5

The biology of interleukin-2.

Malek TR. Malek TR. Annu Rev Immunol. 2008;26:453-79. doi: 10.1146/annurev.immunol.26.021607.090357. Annu Rev Immunol. 2008. PMID: 18062768 Review.

6

IL-2 family of cytokines in T regulatory cell development and homeostasis.

Malek TR, Yu A, Zhu L, Matsutani T, Adeegbe D, Bayer AL. Malek TR, et al. J Clin Immunol. 2008 Nov;28(6):635-9. doi: 10.1007/s10875-008-9235-y. Epub 2008 Aug 26. J Clin Immunol. 2008. PMID: 18726679

7

A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.

Yu A, Zhu L, Altman NH, Malek TR. Yu A, et al. Among authors: malek tr. Immunity. 2009 Feb 20;30(2):204-17. doi: 10.1016/j.immuni.2008.11.014. Epub 2009 Jan 29. Immunity. 2009. PMID: 19185518 Free PMC article.

8

CD4(+) CD25(+) Foxp3(+) T regulatory cells with limited TCR diversity in control of autoimmunity.

Adeegbe D, Matsutani T, Yang J, Altman NH, Malek TR. Adeegbe D, et al. Among authors: malek tr. J Immunol. 2010 Jan 1;184(1):56-66. doi: 10.4049/jimmunol.0902379. Epub 2009 Nov 30. J Immunol. 2010. PMID: 19949075 Free PMC article.

9

Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance.

Adeegbe D, Levy RB, Malek TR. Adeegbe D, et al. Among authors: malek tr. Blood. 2010 Mar 11;115(10):1932-40. doi: 10.1182/blood-2009-08-238584. Epub 2009 Dec 29. Blood. 2010. PMID: 20040758 Free PMC article.

10

Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Malek TR, Castro I. Malek TR, et al. Immunity. 2010 Aug 27;33(2):153-65. doi: 10.1016/j.immuni.2010.08.004. Immunity. 2010. PMID: 20732639 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters